ORTHOPEDIATRICS CORP 8-K

What Happened

• On June 4, 2026, OrthoPediatrics Corp. (KIDS) held its 2026 Annual Meeting and reported the voting results. Four directors were elected to serve until the 2029 Annual Meeting: George S. M. Dyer (For: 10,843,747; Withheld: 8,009,267; Broker non-votes: 1,827,535), Kelly Fischer (For: 18,535,024; Withheld: 317,990; Broker non-votes: 1,827,535), David R. Pelizzon (For: 18,056,773; Withheld: 796,241; Broker non-votes: 1,827,535), and Harald Ruf (For: 18,077,260; Withheld: 775,754; Broker non-votes: 1,827,535).
• Shareholders approved, on an advisory basis, the compensation of the company’s named executive officers (For: 15,953,457; Against: 2,859,793; Abstain: 39,764; Broker non-votes: 1,827,535).
• Shareholders approved an amendment to the 2024 Incentive Award Plan to add 2,050,000 shares (increasing the authorized total to 3,679,000) (For: 18,545,409; Against: 272,115; Abstain: 35,490; Broker non-votes: 1,827,535).
• Shareholders approved the Audit Committee’s appointment of Deloitte & Touche LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 (For: 20,479,183; Against: 154,131; Abstain: 47,235).

Key Details

• Directors elected serve until the 2029 Annual Meeting.
• 2,050,000 additional shares authorized under the 2024 Incentive Award Plan, bringing the total to 3,679,000 shares.
• Say-on-pay (advisory) approved: 15,953,457 votes for vs. 2,859,793 against.
• Deloitte & Touche LLP approved as auditor for FY2026 with 20,479,183 votes in favor.

Why It Matters

• Board control: The elected directors will shape strategy and governance through the 2029 meeting, so the outcomes directly affect oversight and long-term direction.
• Shareholder-approved plan increase raises the pool available for equity awards, which can affect dilution and employee compensation incentives — investors should note the added 2,050,000-share authorization.
• The advisory approval of executive compensation signals majority shareholder support (non-binding) for current pay practices.
• Auditor appointment confirms Deloitte as the independent auditor for next fiscal year, which matters for financial reporting and audit continuity.